Cell-Penetrating Peptides as Carriers for Transepithelial Drug Delivery In Vitro

Author(s):  
Stine Rønholt ◽  
Mie Kristensen ◽  
Hanne Mørck Nielsen
Molecules ◽  
2015 ◽  
Vol 20 (7) ◽  
pp. 13313-13323 ◽  
Author(s):  
Tore Skotland ◽  
Tore Iversen ◽  
Maria Torgersen ◽  
Kirsten Sandvig

2010 ◽  
Vol 15 (23-24) ◽  
pp. 1103-1103
Author(s):  
Monerah H. Al-Soraj ◽  
Catherine L. Watkins ◽  
Dries Vercauteren ◽  
Stefaan De Smedt ◽  
Kevin Braeckmans ◽  
...  

2019 ◽  
Vol 41 (11) ◽  
pp. 1283-1298 ◽  
Author(s):  
Saba Davoodi ◽  
Azam Bolhassani ◽  
Seyed Mehdi Sadat ◽  
Shiva Irani

ChemNanoMat ◽  
2020 ◽  
Vol 6 (8) ◽  
pp. 1138-1148
Author(s):  
Lin Gui ◽  
Xue‐Hao Zhang ◽  
Zeng‐Ying Qiao ◽  
Hao Wang

Pharmaceutics ◽  
2021 ◽  
Vol 13 (10) ◽  
pp. 1618
Author(s):  
Kristina Kiisholts ◽  
Kaido Kurrikoff ◽  
Piret Arukuusk ◽  
Ly Porosk ◽  
Maire Peters ◽  
...  

Gene therapy is a powerful tool for the development of new treatment strategies for various conditions, by aiming to transport biologically active nucleic acids into diseased cells. To achieve that goal, we used highly potential delivery vectors, cell-penetrating peptides (CPPs), as oligonucleotide carriers for the development of a therapeutic approach for endometriosis and cancer. Despite marked differences, both of these conditions still exhibit similarities, like excessive, uncoordinated, and autonomous cellular proliferation and invasion, accompanied by overlapping gene expression patterns. Thus, in the current study, we investigated the therapeutic effects of CPP and siRNA nanoparticles using in vitro models of benign endometriosis and malignant glioblastoma. We demonstrated that CPPs PepFect6 and NickFect70 are highly effective in transfecting cell lines, primary cell cultures, and three-dimensional spheroids. CPP nanoparticles are capable of inducing siRNA-specific knockdown of therapeutic genes, ribonucleotide reductase subunit M2 (RRM2), and vascular endothelial growth factor (VEGF), which results in the reduction of in vitro cellular proliferation, invasion, and migration. In addition, we proved that it is possible to achieve synergistic suppression of endometriosis cellular proliferation and invasion by combining gene therapy and hormonal treatment approaches by co-administering CPP/siRNA nanoparticles together with the endometriosis-drug danazol. We suggest a novel target, RRM2, for endometriosis therapy and as a proof-of-concept, we propose a CPP-mediated gene therapy approach for endometriosis and cancer.


2019 ◽  
Vol 16 (9) ◽  
pp. 3727-3743 ◽  
Author(s):  
Shang Eun Park ◽  
Muhammad Imran Sajid ◽  
Keykavous Parang ◽  
Rakesh Kumar Tiwari

Author(s):  
Maria Luisa García ◽  
Yolanda Pérez ◽  
María José Gómara ◽  
Aimee Vasconcelos ◽  
Estefania Vega ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document